Replies to post #1439 on Immune Pharmaceuticals Inc (fka IMNPQ)

[Investor100]

Boston Biotech Conference-January 8th,2017.

East /West CEO

R&D Trends: What's Changed in the Pharma Pipeline?
Tom Heyman, President, Johnson & Johnson Innovation, JJDC; Vivek Ramaswamy, CEO, Roivant Sciences and Axovant Sciences; Daniel Teper, CEO, Immune Pharmaceuticals
Moderator: Joel Marcus, CEO, Alexandria Ventures

https://bbbiotechconference.com/conference-agenda.php?id=54

Investor 100

[Investor100]

IMNP @ Stockcharts

Nice MOMO day with key indicators up RSI, MACD, MFI...closing at .214 +9.18% 7.7M shares traded...pleased to have bought the dips!



Investor 100